- Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series
-
Takeuchi I, Suzuki T, Kishi T, Kanamori D, Hanya M, Uno J, Fujita K, Kamei H
- KMID: 2171071
- Clin Psychopharmacol Neurosci.
- 2015 Apr;13(1):109-112.
- doi: 10.9758/cpn.2015.13.1.109
Clozapine has been demonstrated to be useful for treating refractory schizophrenia. However, hypersalivation occurs in 31.0-97.4% of the patients treated with clozapine. Accordingly, some patients who are disturbed by their... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Adenine on Clozapine-induced Neutropenia in Patients with Schizophrenia: A Preliminary Study
-
Takeuchi I, Kishi T, Hanya M, Uno J, Fujita K, Kamei H
- KMID: 2171046
- Clin Psychopharmacol Neurosci.
- 2015 Aug;13(2):157-162.
- doi: 10.9758/cpn.2015.13.2.157
OBJECTIVE: This study examined the utility of adenine for preventing clozapine-induced neutropenia. METHODS: This retrospective study examined the effect of adenine on clozapine-induced neutropenia in patients with treatment-resistant schizophrenia and was... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Levels of Brain-Derived Neurotrophic Factor at 4 Weeks and Response to Treatment with SSRIs
-
Yoshimura , Kishi T, Hori H, Katsuki A, Sugita-Ikenouchi A, Umene-Nakano W, Atake K, Iwata N, Nakamura J
- KMID: 2316335
- Psychiatry Investig.
- 2014 Jan;11(1):84-88.
OBJECTIVE: It is important to predict a response to an antidepressant in early time after starting the antidepressant. We previously reported that serum brain-derived neurotrophic factor (BDNF) levels in responders... -
- CITED
-
- Close
- SHARE
-
- Close
- No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients
-
Yoshimura , Kishi T, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Katsuki A, Hayashi K, Iwata N, Nakamura J
- KMID: 2134674
- Clin Psychopharmacol Neurosci.
- 2012 Apr;10(1):49-53.
OBJECTIVE: This study examined the association between the brain-derived neurotrophic factor (BDNF) (Val66Met) polymorphism and the response to the addition of an atypical antipsychotic drug to a selective serotonin reuptake... -
- CITED
-
- Close
- SHARE
-
- Close
